AzTrials
AzTrials

Burn InjuryBURN-PREDNCT07689890

Burn Mortality Prediction Scores

An observational study of Burn Injury and In-Hospital Mortality, run by Gaziantep City Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This retrospective observational cohort study evaluates hospitalized burn admissions treated at the Burn Center of Gaziantep City Hospital between October 2023 and February 2026. Read more about this study

Who is it for?
Any age
Conditions the study is for
Burn Injury, In-Hospital Mortality
What is being tested?
Retrospective Prognostic Score Assessment
How many people
1,082 participants
Where
1 siteTurkey (Türkiye)
Study dates
7 Oct 2023to 28 Feb 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study population consists of hospitalized burn admissions treated at the Burn Center of Gaziantep City Hospital, a tertiary referral burn center, between October 2023 and February 2026. The cohort includes burn admissions with documented in-hospital outcomes and sufficient electronic medical record data for calculation of ABSI, Revised Baux score, and modified Ryan score.

Inclusion Criteria: Hospitalized burn admissions treated at the Burn Center of Gaziantep City Hospital between October 2023 and February 2026.

Admissions with a documented in-hospital outcome of discharge alive or death. Admissions with available electronic medical records for age, sex, total body surface area burned, burn depth, inhalation injury, and core clinical variables.

Exclusion Criteria: Admissions transferred to another facility before final clinical outcome assessment.

Admissions in which treatment was refused. Admissions without sufficient electronic medical record data for calculation of the prognostic scores or assessment of the primary outcome.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gaziantep City Hospital Burn Center

    Gaziantep, Gaziantep, 27470

Other trials in Turkey (Türkiye)

About this study

Official title: Comparative Performance of ABSI, Revised Baux Score, and Modified Ryan Score for In-Hospital Mortality Prediction in Hospitalized Burn Admissions: A Retrospective Cohort Study

This retrospective observational cohort study evaluates hospitalized burn admissions treated at the Burn Center of Gaziantep City Hospital between October 2023 and February 2026. The study aims to compare the ability of three burn severity scoring systems, the Abbreviated Burn Severity Index (ABSI), Revised Baux score, and modified Ryan score, to predict in-hospital mortality.

Electronic medical records were reviewed for demographic characteristics, burn-related variables, inhalation injury, burn depth, intensive care admission, mechanical ventilation, sepsis, surgical procedures, length of hospital stay, and survival status at hospital discharge. The primary outcome is in-hospital mortality. The predictive performance of the scoring systems will be evaluated using receiver operating characteristic analysis and logistic regression.

Read the detailed description

Burn injuries are associated with substantial morbidity, mortality, intensive care use, prolonged hospitalization, and surgical burden. Early identification of patients at high risk of death may support clinical triage, intensive care planning, resource allocation, and communication with patients' families.

This study is a single-center, retrospective, observational cohort study conducted at the Burn Center of Gaziantep City Hospital, a tertiary referral burn center serving southern Türkiye and cross-border regions. The study includes hospitalized burn admissions treated between October 2023 and February 2026.

A total of 1315 burn admission records were screened. Admissions transferred to another facility before final clinical outcome assessment and admissions in which treatment was refused were excluded. After applying eligibility criteria, 1082 hospitalized burn admissions were included in the primary analysis cohort.

The study evaluates the prognostic performance of the Abbreviated Burn Severity Index (ABSI), Revised Baux score, and modified Ryan score for predicting in-hospital mortality. ABSI is calculated using age, sex, total body surface area burned, inhalation injury, and full-thickness burn status. Revised Baux score is calculated using age, total body surface area burned, and the presence of inhalation injury. The modified Ryan score is calculated using age category, total body surface area burned category, inhalation injury, and third-degree burn status.

The primary outcome is in-hospital mortality, defined as death occurring during the index hospitalization. Secondary evaluations include associations between mortality and selected clinical variables, including inhalation injury, sepsis, intensive care admission, mechanical ventilation, number of surgical procedures, and length of hospital stay.

The discriminative performance of prognostic scores will be assessed using receiver operating characteristic analysis. Area under the curve, confidence intervals, optimal cut-off values, sensitivity, and specificity will be reported. Associations between score increments and mortality will be examined using univariable logistic regression.

Being tested
Retrospective Prognostic Score Assessment
Keywords
ABSI, Revised Baux score, Modified Ryan score, Burn mortality, In-hospital mortality, Prognostic score, Retrospective cohort, Total body surface area burned, Inhalation injury, ROC analysis
Medical subject headings
Burns

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Retrospective Prognostic Score AssessmentOther

    Also called ABSI, Revised Baux score, Modified Ryan score

    ABSI, Revised Baux score, and modified Ryan score were retrospectively calculated using routinely collected electronic medical record data from hospitalized burn admissions. These scores were evaluated for their ability to predict in-hospital mortality. No drug, device, procedure, or treatment intervention was assigned by the study protocol.

Study groups in NCT07689890
Study groupRoleWhat they receive
Hospitalized Burn AdmissionsHospitalized burn admissions treated at the Burn Center of Gaziantep City Hospital between October 2023 and February 2026 and included in the retrospective primary analysis cohort. Prognostic scores, including ABSI, Revised Baux score, and modified Ryan score, were calculated from routinely recorded electronic medical data. No intervention was assigned by the study protocol.
Receives: Other: Retrospective Prognostic Score Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. In-Hospital Mortality

    In-hospital mortality was defined as death occurring during the index hospitalization for burn injury. Mortality status was determined from electronic hospital records and was used as the primary outcome for evaluating the prognostic performance of burn severity scoring systems.

    Measured: From hospital admission to hospital discharge or in-hospital death, assessed up to 240 days.

Secondary outcomes (4)
  1. Area Under the Receiver Operating Characteristic Curve for the Abbreviated Burn Severity Index

    The Abbreviated Burn Severity Index was calculated using age, sex, total body surface area burned, inhalation injury, and full-thickness burn status recorded in electronic hospital records. Higher scores indicate greater burn severity and higher predicted mortality risk. Predictive discrimination for in-hospital mortality was evaluated using the area under the receiver operating characteristic curve. The area under the curve ranges from 0.0 to 1.0, with higher values indicating better discriminative performance.

    Measured: Score variables were obtained from admission and early hospitalization records; in-hospital mortality was assessed from hospital admission to discharge or in-hospital death, up to 240 days.

  2. Area Under the Receiver Operating Characteristic Curve for the Revised Baux Score

    The Revised Baux score was calculated using age, total body surface area burned, and the presence of inhalation injury. Higher scores indicate greater burn severity and higher predicted mortality risk. Predictive discrimination for in-hospital mortality was evaluated using the area under the receiver operating characteristic curve. The area under the curve ranges from 0.0 to 1.0, with higher values indicating better discriminative performance.

    Measured: Score variables were obtained from admission and early hospitalization records; in-hospital mortality was assessed from hospital admission to discharge or in-hospital death, up to 240 days.

  3. Predictive Performance of the Modified Ryan Score

    The predictive performance of the modified Ryan score for in-hospital mortality was evaluated using receiver operating characteristic analysis. Area under the curve, 95% confidence interval, optimal cut-off value, sensitivity, and specificity were calculated.

    Measured: Score variables were obtained from admission and early hospitalization records; in-hospital mortality was assessed from hospital admission to discharge or in-hospital death, up to 240 days.

  4. Association of Selected Clinical Factors With In-Hospital Mortality

    The association of selected clinical factors, including inhalation injury, sepsis, intensive care admission, mechanical ventilation, number of surgical procedures, and length of hospital stay, with in-hospital mortality was evaluated using appropriate statistical analyses.

    Measured: Clinical factors and mortality status were assessed from hospital admission to hospital discharge or in-hospital death, up to 240 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2026
  2. Study start7 Oct 2023
  3. Primary completion28 Feb 2026
  4. Study completion28 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,082 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07689890
Sponsor's protocol ID
GCH-BURN-SCORES-2026
Acronym
BURN-PRED
Status last verified
Jun 2026
First submitted
22 Jun 2026
Last updated
8 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ryan CM, Schoenfeld DA, Thorpe WP, Sheridan RL, Cassem EH, Tompkins RG. Objective estimates of the probability of death from burn injuries. N Engl J Med. 1998 Feb 5;338(6):362-6. doi: 10.1056/NEJM199802053380604.

    PubMed 9449729
  • Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries: extending and updating the baux score. J Trauma. 2010 Mar;68(3):690-7. doi: 10.1097/TA.0b013e3181c453b3.

    PubMed 20038856
  • Tobiasen J, Hiebert JM, Edlich RF. The abbreviated burn severity index. Ann Emerg Med. 1982 May;11(5):260-2. doi: 10.1016/s0196-0644(82)80096-6. No abstract available.

    PubMed 7073049

Questions about this trial

What is this clinical trial studying?

An observational study of Burn Injury and In-Hospital Mortality, run by Gaziantep City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

In-Hospital Mortality (time frame: From hospital admission to hospital discharge or in-hospital death, assessed up to 240 days.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07689890, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in